Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability

Overview of attention for article published in Frontiers in oncology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,462 followers.

New article: Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability https://t.co/g1UJihC1QQ #colorectalcancer #oncology https://t.co/hhcDU6TLCm

01 Jul 2022

Reply Repost Favourite

📣Original Research Article: Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the #ColorectalCancer With Microsatellite Stability 👨‍⚕️👩‍⚕️ Yu G et al Read here 👉 https://t.co/sHnzg7Y3kZ #CancerTreatment #Immuno

19 Jun 2022

Reply Repost Favourite

New research: Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability: Patients of colorectal cancer (CRC) with microsatellite stability (MSS) show poor… https://t.co/

14 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.